HYPD
Hyperion DeFi, Inc. · Healthcare
3.30
1.54%(+0.05)
Prev. Close3.33
0.91%(+0.03)
Pre-marketLast Updated: — ET
52W L: $0.8552W H: $17.18
$3.21
CHG+0.06 (+1.90%)
H$4.03
L$2.92
VOL6.3M
HYPD (1h)
HYPD NEWS
defenseworld.net
8h ago
Hyperion DeFi (NASDAQ:HYPD) versus Neuren Pharmaceuticals (OTCMKTS:NURPF) Critical Survey
Hyperion DeFi (NASDAQ: HYPD - Get Free Report) and Neuren Pharmaceuticals (OTCMKTS:NURPF - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, earnings, analyst recommendations, profitability and risk. Valuation and Earnings This table compares Hyperion DeFi
seekingalpha.com
Mar 26
Hyperion DeFi, Inc. (HYPD) Q4 2025 Earnings Call Transcript
Hyperion DeFi, Inc. (HYPD) Q4 2025 Earnings Call Transcript
globenewswire.com
Mar 26
Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit
Five Diversified, Ramping DeFi Business Lines Delivered Growth Exceeding Q4 Guidance Treasury Exceeds 1.93M HYPE, 1.92M KNTQ, & 1.00M HPL Tokens as of March 23 (14) HYPD's Unique “Triple-Dip” HYPE Deployment Generated ~3x Base Staking Income in Q4 Announces Executed LOI to Monetize the Optejet, With Potential Closing in Q2'26 LAGUNA HILLS, Calif., March 26, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today reported results for the fourth quarter and full year ending December 31, 2025.
defenseworld.net
Mar 16
Hyperion DeFi, Inc. (NASDAQ:HYPD) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Hyperion DeFi, Inc. (NASDAQ: HYPD - Get Free Report) have earned an average rating of "Hold" from the five ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to
globenewswire.com
Mar 9
Hyperion DeFi Announces Private Lending Pool Built by HyperLend
Unlocks Cost-Optimized On-Chain Credit Access, Additional Ecosystem Rewards, and Expanded Revenue Opportunities in Institutional Credit Unlocks Cost-Optimized On-Chain Credit Access, Additional Ecosystem Rewards, and Expanded Revenue Opportunities in Institutional Credit
defenseworld.net
Mar 9
Zelira Therapeutics (OTCMKTS:ZLDAF) and Hyperion DeFi (NASDAQ:HYPD) Critical Analysis
Hyperion DeFi (NASDAQ: HYPD - Get Free Report) and Zelira Therapeutics (OTCMKTS:ZLDAF - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Valuation and Earnings This table compares Hyperion DeFi